Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
177 Native and engineered allogenic invariant natural killer T (iNKT) cells eliminate senescent tumor cells and fibroblasts in oncogenic in vitro models
5 affiliations
- 1Department of Medical Oncology, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
- 22Agenus, Lexington, MA, USA
- 3Department of Oncology, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, Zhejiang, China
- 4MiNK Therapeutics, Lexington, MA, USA
- 5MRC London Institute of Medical Sciences, Imperial College London, London, UK
Related
- Senescent Fibroblasts Impair B Cell Proliferation via Cell-Cell Contact.
- Syngeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide to induce immune tolerance of allogenic skin graft survival in rat.
- Knock, knock - who's there? Doorway event boundaries weaken but do not eliminate bindings in first-person perspective environments.
- T-cell metabolic reprogramming in systemic lupus erythematosus: linking intracellular metabolism to effector differentiation and senescent-like/exhausted-like states
- Senescent-Like Neutrophils Shape Angiogenic Immunosuppressive Niches in Colorectal Cancer Liver Metastasis
BibTeX
@article{sun2026native,
title = {{177 Native and engineered allogenic invariant natural killer T (iNKT) cells eliminate senescent tumor cells and fibroblasts in oncogenic in vitro models}},
author = {Yan Sun and Nils-Petter Rudqvist and Jing Fang and Olivier Le Tonqueze and Erika L Smith-Mahoney and Terese C Hammond and Marco A Purbhoo and Jennifer S Buell and Jesus Gil},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.0177},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.0177},
note = {CC BY},
}
RIS
TY - JOUR
TI - 177 Native and engineered allogenic invariant natural killer T (iNKT) cells eliminate senescent tumor cells and fibroblasts in oncogenic in vitro models
AU - Yan Sun
AU - Nils-Petter Rudqvist
AU - Jing Fang
AU - Olivier Le Tonqueze
AU - Erika L Smith-Mahoney
AU - Terese C Hammond
AU - Marco A Purbhoo
AU - Jennifer S Buell
AU - Jesus Gil
PY - 2026
DA - 2026/11/04
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.0177
UR - https://doi.org/10.1136/jitc-2026-sitc2026.0177
SN - 2051-1426
ER -